|
ATAD5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.379900E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.155600E-03 |
| Normal-vs-Stage2 |
6.44049999999341E-05 |
| Normal-vs-Stage3 |
3.883700E-03 |
| Normal-vs-Stage4 |
4.157800E-03 |
| Stage1-vs-Stage2 |
1.998000E-03 |
| Stage1-vs-Stage3 |
5.179800E-01 |
| Stage1-vs-Stage4 |
4.954600E-01 |
| Stage2-vs-Stage3 |
4.074200E-02 |
| Stage2-vs-Stage4 |
9.988400E-02 |
| Stage3-vs-Stage4 |
8.778600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.918600E-03 |
| Normal-vs-AfricanAmerican |
3.765500E-02 |
| Normal-vs-Asian |
4.881800E-02 |
| Caucasian-vs-AfricanAmerican |
9.029400E-01 |
| Caucasian-vs-Asian |
3.657800E-01 |
| AfricanAmerican-vs-Asian |
6.394800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.256300E-03 |
| Normal-vs-Female |
2.359700E-03 |
| Male-vs-Female |
8.777400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.433670E-02 |
| Normal-vs-Age(41-60Yrs) |
6.978500E-04 |
| Normal-vs-Age(61-80Yrs) |
3.222900E-03 |
| Normal-vs-Age(81-100Yrs) |
1.834760E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.611800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.592800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.506800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.493400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.051600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.728200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.358400E-01 |
| Classical-VS-Follicular |
7.92809999999866E-05 |
| Classical-VS-Other |
3.566000E-01 |
| Classical-VS-Normal |
1.364410E-02 |
| Tall-VS-Follicular |
4.934300E-02 |
| Tall-VS-Other |
5.228200E-01 |
| Tall-VS-Normal |
1.820130E-02 |
| Follicular-VS-Other |
6.862000E-01 |
| Follicular-VS-Normal |
5.72349999999888E-05 |
| Other-VS-Normal |
1.290590E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.162730E-03 |
| Normal-vs-N1 |
3.143900E-02 |
| N0-vs-N1 |
1.137210E-01 |
|
|
